This product is CE marked in Europe, where it has a leading position for lung cancer screening tools.Īidence’s solution analyses thousands of CT scans each week, with customers in seven European countries, including France, the Netherlands, and the UK. Aidence’s first commercialised product, Veye Lung Nodules, is an AI-based solution for lung nodule detection classification, quantification, and growth assessment. RadNet, a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services today reported it has acquired Aidence, a leading radiology AI company focusing on AI-enabled clinical solutions for pulmonary nodule management in routine practice and lung cancer screening.įounded in 2015 and based in Amsterdam, the Netherlands, Aidence is developing and deploying AI clinical applications to empower radiologists and other physicians in interpreting medical images and improving patient outcomes.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |